Skip to content

Dogwood Therapeutics DWTX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$3.98M-28.3%
Bioventus logo
BioventusBVS
5.2%0.0pp
Avanos Medical logo
Avanos MedicalAVNS
$39.3M+22.4%
LON
LeonaBio, Inc. Common StockLONA
$461K-38.0%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$4.88M+289%
PTH
Pelthos Therapeutics Inc.PTHS
8.4%

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's operating lease ROU assets?
Dogwood Therapeutics (DWTX) reported operating lease ROU assets of $146.75K in Q1 2026.
How has Dogwood Therapeutics's operating lease ROU assets changed year-over-year?
Dogwood Therapeutics's operating lease ROU assets decreased by 24.3% year-over-year, from $193.76K to $146.75K.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.